Health

New Delhi, Jan 3 : The Central Licensing Authority on Sunday granted permission to Hyderabad-based Bharat Biotech to manufacture ‘Covaxin’ for sale and distribution, after the indigenous coronavirus vaccine received regulatory approval for emergency …

New Delhi, Jan 3 : The Delhi government on Sunday announced it would run 500 to 600 Covid centres in the first phase of vaccination soon after the Drug Controller General of India (DCGI) gives approval to Serum Institute of India’s ‘Covishield’ vacci…

New Delhi, Jan 3 : The Central Licensing Authority on Saturday granted permission to Hyderabad-based Bharat Biotech to manufacture ‘Covaxin’ for sale and distribution, after the indigenous coronavirus vaccine received regulatory approval for emergenc…

Jammu, Jan 3 : Jammu and Kashmir on Sunday saw 205 Covid-19 patients recover while there were 182 new cases during the last 24 hours.An official bulletin said that of the new cases comprised 103 in the Jammu division and 79 in the Kashmir division.So…

New Delhi, Jan 3 : For the first time in the last seven and a half months, the number of Covid-19 cases has gone below 500 in the national capital with only 424 fresh infections reported in the last 24 hours as on Sunday.As per the latest health bull…

Chandigarh, Jan 3 : Punjab is fully prepared with a capacity to vaccinate 4 lakh people a day, state Health Minister Balbir Sidhu said on Sunday.He said the state has established a robust storage capacity of one crore vaccines.It has also achieved mo…

Bengaluru, Jan 3 : Union Chemicals and Fertilisers Minister D.V. Sadananda Gowda suddenly fell sick in Karnataka’s Chitradurga town and was rushed to Bengaluru for treatment, an official said on Sunday.”Gowda, 67, suddenly fell ill at Chitradurga due…

New Delhi, Jan 3 : Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.G.Somani on Sunday approved Serum Institute of India’s ‘Covishield’ vaccine and Bharat Biotech’s ‘Covaxin’ fo…

New Delhi, Jan 3 : Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.G.Somani on Sunday approved Serum Institute of India’s ‘Covishield’ vaccine and Bharat Biotech’s ‘Covaxin’ fo…

New Delhi, Jan 3 : Adar Poonawalla, CEO, Serum Institute of India (SII) said on Sunday that the Covishield, India’s first Covid-19 vaccine will roll out in the coming weeks.Poonawalla said SII risks on stockpiling the vaccine have paid off.His statem…